RHYTHM PHARMACEUTICALS, INC. — Director's Dealing 2019

Jun 21, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RHYTHM PHARMACEUTICALS, INC. (RYTM)
CIK: 0001649904
Period of Report: 2019-06-19

Reporting Person: Foley Todd (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-06-19	Stock Option (right to buy)	$22.93	A	15000	Acquired	2029-06-18	Common Stock (15000)	Direct

Footnotes

F1: The options fully vest upon the earlier of (i) 1 year from the date of grant or (ii) the date of the Issuer's next annual meeting of the stockholders.